Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romiplostim for post-transplant thrombocytopenia in pediatric patients
IRCT20150730023417N2Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Mar 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of romiplostim in Thrombocytopenia, sponsored by Tehran University of Medical Sciences. Primary endpoints: Platelet response, Platelet count change and 7 more. Started Mar 2023; status: completed.
02
Drugs
romiplostim
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on IRCT20150730023417N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150730023417N2.